Adirna Therapeutics, Inc.
Adirna Therapeutics uses AI and big data to target RNA-based diseases with precision therapeutics. It analyzes the dark genome to identify regulatory non-coding RNAs and validate targets and biomarkers. The core tech includes a proprietary database and AI-powered platforms that enable efficient discovery. The company operates in biotech and partners with pharma and research groups to advance therapies. This approach aims to address high unmet medical needs at scale.
Adirna Therapeutics, Inc.
Adirna Therapeutics uses AI and big data to target RNA-based diseases with precision therapeutics. It analyzes the dark genome to identify regulatory non-coding RNAs and validate targets and biomarkers. The core tech includes a proprietary database and AI-powered platforms that enable efficient discovery. The company operates in biotech and partners with pharma and research groups to advance therapies. This approach aims to address high unmet medical needs at scale.